| Full Name | Thuy Nguyen |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3600 Broadway, Oakland, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154855211 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 58763 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Thuy Nguyen, 1176 Fairway Dr, El Sobrante, CA 94803-1263 Ph: () - | Thuy Nguyen, 3600 Broadway, Oakland, CA 94611-5730 Ph: (510) 752-4209 |
News Archive
Signal Genetics, a privately held predictive genetic testing company focusing on oncology, and DiagnoCure, Inc., a life sciences company that develops and commercializes high-value cancer diagnostic tests, today announced a collaboration arrangement valued at US$13.3M over the first five years.
Distinct from virus transmission patterns identified elsewhere, analysis of SARS-CoV-2 genomes from a small number of California-based patients suggests the virus arrived in northern California through a complex series of introductions, not only from state to state but also from international travel.
The La Jolla Institute for Immunology (LJI) is partnering with Synbal, Inc., a preclinical biotechnology company based in San Diego, CA, to develop multi-gene, humanized mouse models for COVID-19 research. The research at LJI will be led by Professor Sujan Shresta, Ph.D., a member of the Institute's Center for Infectious Disease and Vaccine Research.
The biotech companies PHARNEXT and BIOSYSTEMS INTERNATIONAL, the Bordeaux Hospital where CMRR is located, the university Bordeaux Segalen and Inserm (the center U897 "Epidemiology and Biostatistics") have joined forces to carry out the DIPPAL2i project. This innovative research and industrial development project is targeting Alzheimer's disease (AD) and has attracted significant financial support from OSEO (the French state innovation agency).
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Tacrolimus Capsules, 0.5 mg, 1 mg and 5 mg, the generic version of Astellas' Prograf® Capsules, a treatment to prevent rejection in people who have received certain organ transplants.
› Verified 6 days ago
Dr. Gachiru L Kamau-devers, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3550 Fruitvale Ave, Oakland, CA 94602 Phone: 510-336-9305 Fax: 510-336-3925 | |
Jessica Chang, PHARM.D., APH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 280 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-8859 | |
Trong-nghia Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3320 Fruitvale Ave, Oakland, CA 94602 Phone: 510-530-3156 Fax: 510-530-1082 | |
Jocelyn Chan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1800 Harrison St Fl 13, Oakland, CA 94612 Phone: 510-625-2139 | |
Norma Miyeko Marubayashi Holloway, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 280 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-6468 | |
Mrs. Michele Ng, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 280 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-6141 | |
Carol K Lam, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1800 Harrison St Ste 1301, Oakland, CA 94612 Phone: 626-941-4706 |